Researchers propose that self-organising peer review for preprints could be the future of scholarly publishing.
Discover the five areas for improvement identified in Springer Nature’s recent surveys of researchers, aiming to promote data sharing.
Many public funders have mandated open access to their research and support Plan S. Should pharmaceutical companies follow suit?
AllTrials seeks support for a new initiative to monitor clinical trial reporting in the UK.
Transparency and reproducibility are now synonymous with medical publications, but actions speak louder than words. A recent study examines whether progress has been made.
The ICMJE recently updated its recommendations, providing guidance on issues such as use of preprint servers, conflict of interest reporting and journal metrics.
A free 90-minute webinar from ISMPP, open to all.
Researchers can win Wellcome Data Re-use Prizes for new insights, tools or health applications generated from re-use of open data.
Are researchers able to access trial data? Audit provides insights on data sharing from industry-sponsored studies
A recent study published in BMC Medicine audits data sharing from pharmaceutical industry-sponsored clinical studies.
UNESCO World Science Day for Peace and Development aims to improve access and diversity in science.
The Wellcome Trust announces a new open access policy, which includes five key updates.
Tim Ellison reviews the growing importance of preprints in medical publishing.
This year’s International Open Access Week (October 22–28) is underway with a focus on designing equitable foundations for open knowledge. A host of events are scheduled across the globe, how will you get involved?
We consider if enough value is placed by academic institutions on efforts to communicate science to the public.
In a recent publication, researchers examine whether funder open access platforms are a good idea.
Robert-Jan Smits, a senior European Commission official comments on whether open access for all scientific papers by 2020 is a realistic goal.